Surrogate end points in heart failure trials

被引:17
作者
Gheorghiade, M
Adams, KF
Gattis, WA
Teerlink, JR
Orlandi, C
O'Connor, CM
机构
[1] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Duke Clin Res Inst, Durham, NC USA
[4] Univ Calif San Francisco, Sch Med, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA
[5] Otsuka Maryland Res Inst, Rockville, MD USA
关键词
D O I
10.1067/mhj.2003.159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S67 / S70
页数:4
相关论文
共 22 条
  • [1] Surrogate end points in heart failure
    Anand, IS
    Florea, VG
    Fisher, L
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (09) : 1414 - 1421
  • [2] A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
    Califf, RM
    Adams, KF
    McKenna, WJ
    Gheorghiade, M
    Uretsky, BF
    McNulty, SE
    Darius, H
    Schulman, K
    Zannad, F
    HandbergThurmond, E
    Harrell, FE
    Wheeler, W
    SolerSoler, J
    Swedberg, K
    [J]. AMERICAN HEART JOURNAL, 1997, 134 (01) : 44 - 54
  • [3] Heart failure 99 - the Moxcon story
    Coats, AJS
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 71 (02) : 109 - 111
  • [4] EFFECT OF VASODILATOR THERAPY ON MORTALITY IN CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF A VETERANS-ADMINISTRATION COOPERATIVE STUDY
    COHN, JN
    ARCHIBALD, DG
    ZIESCHE, S
    FRANCIOSA, JA
    HARSTON, WE
    TRISTANI, FE
    DUNKMAN, WB
    JACOBS, W
    FRANCIS, GS
    FLOHR, KH
    GOLDMAN, S
    COBB, FR
    SHAH, PM
    SAUNDERS, R
    FLETCHER, RD
    LOEB, HS
    HUGHES, VC
    BAKER, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (24) : 1547 - 1552
  • [5] A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE
    COHN, JN
    JOHNSON, G
    ZIESCHE, S
    COBB, F
    FRANCIS, G
    TRISTANI, F
    SMITH, R
    DUNKMAN, WB
    LOEB, H
    WONG, ML
    BHAT, G
    GOLDMAN, S
    FLETCHER, RD
    DOHERTY, J
    HUGHES, CV
    CARSON, P
    CINTRON, G
    SHABETAI, R
    HAAKENSON, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) : 303 - 310
  • [6] MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL
    ECHT, DS
    LIEBSON, PR
    MITCHELL, LB
    PETERS, RW
    OBIASMANNO, D
    BARKER, AH
    ARENSBERG, D
    BAKER, A
    FRIEDMAN, L
    GREENE, HL
    HUTHER, ML
    RICHARDSON, DW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) : 781 - 788
  • [7] Eichhorn E, 2001, NEW ENGL J MED, V344, P1659
  • [8] EFFECTS OF VESNARINONE ON MORBIDITY AND MORTALITY IN PATIENTS WITH HEART-FAILURE
    FELDMAN, AM
    BRISTOW, MR
    PARMLEY, WW
    CARSON, PE
    PEPINE, CJ
    GILBERT, EM
    STROBECK, JE
    HENDRIX, GH
    POWERS, ER
    BAIN, RP
    WHITE, BG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) : 149 - 155
  • [9] Surrogate end points in clinical trials: Are we being misled?
    Fleming, TR
    DeMets, DL
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) : 605 - 613
  • [10] Hjalmarson Å, 1999, LANCET, V353, P2001